Researchers monitored patients for complications and deaths within 30 days of surgery.

Volatilities of different features are highly correlated with their divergence in longitudinally monitored patients.

The researchers also monitored patients' blood levels of hemoglobin A1c, which reflect blood sugar levels over time.

A trained observer monitored patients for 72 triggers, which were predefined occurrences deemed likely to indicate an actual or potential adverse event.

Closely monitored patients with CML treated with imatinib at an NCCN Member Institution experienced outcomes comparable to those reported in key clinical trials.

Unfortunately, the AHA Practice Standards have not been widely adopted-with as many as 43% of monitored patients lacking a recommended indication for monitoring.